Jump to content

Angiotensin-converting enzyme 2: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

28 March 2025

9 May 2024

4 May 2024

19 March 2024

10 March 2024

29 January 2024

17 January 2024

  • curprev 21:5721:57, 17 January 2024 Keith D talk contribs 44,597 bytes −37 Fix cite date error undo Tag: AWB
  • curprev 19:1719:17, 17 January 2024 Valral101 talk contribs 44,634 bytes +694 The opening statement that mACE2 does not contribute to serum RAS peptides and blood pressure control is not factual. It is long known that tissue ACE1 is the major contributor to serum RAS peptides and blood pressure control (Esther, et al. 1997: https://pubmed.ncbi.nlm.nih.gov/9153279/), and ACE2 is likely to work similarly. If someone would to dispute it, please give suitable a reference, as the original statement was not referenced. Also, bad RAAS isn't a good term - low BP is dangerous too undo Tag: Visual edit

13 December 2023

11 December 2023

16 August 2023

13 August 2023

11 August 2023

3 August 2023

16 June 2023

20 May 2023

26 March 2023

25 March 2023

17 March 2023

13 February 2023

29 January 2023

22 January 2023

11 November 2022

16 August 2022

6 July 2022

17 May 2022

5 May 2022

23 April 2022

21 April 2022

20 April 2022

14 April 2022

7 April 2022

14 March 2022

26 February 2022

24 February 2022

2 February 2022

1 February 2022

14 January 2022

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)